As France votes to give its residents suffering from incurable illness the right to assisted dying, research finds that public perception has become increasingly favourable to euthanasia – despite critics calling it a ‘shortcut’
The US supplies a quarter of EU plasma, and now they’re in a supply crisis. Although that doesn’t mean an imminent emergency in Brussels, the EU needs to get ahead in its external dependence on life-giving products like plasma.
Europe is right to strengthen stockpiles, early-warning systems, and civil defence. But the decisive question is not whether every person can survive 72 hours alone. It is whether Europe has designed its preparedness so that no one is abandoned during those hours.
By racing ahead of the currently stalled EU process, Sweden joins a small group of member states using national bans on ‘forever chemicals’.
While studies link microplastics to behavioural problems in children and potential cancer risks, questions from MEPs to the European Commission about food and product safety remain unanswered.
With France now joining just five other EU countries that permit assisted dying, millions of Europeans still face radically different choices over how they can end unbearable suffering, depending purely on which border they live behind.
Heart disease, cancer, menopause and endometriosis: millions of European women are paying the price of late diagnoses, underfunded research and medicines never properly tested on their bodies.
The risks of Ebola cases in the EU is still “very low”, the European Centre for Disease Prevention and Control has said. But it has still urged EU states to boost their preparedness.
The grim forecast, announced on Wednesday by the European Centre for Disease Prevention and Control points to a resurgence of HIV, TB, viral hepatitis, and other sexual transmitted infections.
French doctors are urging stricter action on PFAS, microplastics, and other water pollutants, while the EU considers easing water regulations to support critical-mineral mining. So what takes priority? Water quality, or battery production in Europe?
The outbreak of Ebola currently hitting the Democratic Republic of the Congo (DRC) is being fueled by armed conflict — but also, and perhaps above all, by the global decline in humanitarian aid.
Why are hundreds of rare disease patients like me still waiting for European Medicines Agency approved drugs?
“The reality is that the frequency and intensity of disease outbreaks are increasing”, warned EU international partnerships commissioner Jozef Sikela on Wednesday, as he unveiled a new agenda to boost supply chains and health ‘sovereignty’.
The EU Commission wants to use its Global Gateway investment programme to finance healthcare projects across Africa, but sharp drops in aid budgets risk leaving millions to die.
Is your baguette a health risk? France’s cadmium levels are three times higher than those of its neighbours, fueled by phosphate fertilisers and industrial legacy. Léa Marchal explores why France lags on safety limits and what this means for people’s daily diet.
The EU is attempting to equalise access to medicines with the biggest reform of the bloc’s medicine laws in 20 years. But Europeans are unlikely to feel the tangible effects of the Pharmaceutical Package, such as shorter waiting times for medicines, until around 2028 at the earliest.
The European Environment Agency warns “according to some estimates, about eight percent of deaths can be attributed to hazardous chemicals. These numbers could be [an] underestimate.” That’s why the EU chemicals REACH policy needs urgent reform.
